Şükran Yılmaz

870 citations
31 papers · 721 indexed · h-index 16
Topics
Nanoparticle-Based Drug Delivery (8 papers)RNA Interference and Gene Delivery (5 papers)Ferrocene Chemistry and Applications (4 papers)
Partner nations
TürkiyeIndia

In The Last Decade

Şükran Yılmaz

31 papers receiving 705 citations

Peers

Şükran Yılmaz
Comparison fields: 5 of 105
  • Molecular Biology 185
  • Biomaterials 166
  • Organic Chemistry 130
  • Biomedical Engineering 119
  • Pharmaceutical Science 118
Replace Rajan Swami with:
Rajan Swami India
Madhu Verma India
Tu Huang China
Ruchadaporn Kaomongkolgit Thailand
A. Yekta Özer Türkiye
Ioannis Tsamesidis Greece
Sevda Jafari Iran
R Parikh India
Neelam Poonia India
Fernando Mendonça Diz Brazil
Şükran Yılmaz relative to Rajan Swami India Rajan Swami's profile →
Citations per field
00.5×1.5×2.1×
Rajan Swami · 1×
Citations per year

Countries citing papers authored by Şükran Yılmaz

Since Specialization
Citations

This map shows the geographic impact of Şükran Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şükran Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şükran Yılmaz more than expected).

Fields of papers citing papers by Şükran Yılmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şükran Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şükran Yılmaz. The network helps show where Şükran Yılmaz may publish in the future.

Co-authorship network of co-authors of Şükran Yılmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Şükran Yılmaz. A scholar is included among the top collaborators of Şükran Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şükran Yılmaz. Şükran Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 24
3 2
4 10
5 22
6 10
7 1
8 5
9 34
10 45
11 3
12 23
13 63
14 25
15 40
16 94
17 14
18 26
19 30
20 30

About Şükran Yılmaz

Şükran Yılmaz is a scholar working on Orthodontics, Biomaterials and Oral Surgery, having authored 31 papers that have together received 721 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (5 papers) and Ferrocene Chemistry and Applications (4 papers). The work is most often cited by research in Orthodontics (103 citations), Pharmaceutical Science (118 citations) and Oral Surgery (99 citations). Şükran Yılmaz has collaborated with scholars based in Türkiye and India. Frequent co-authors include Zelihagül Değim, Handan Yılmaz, Levent Altıntaş, Meltem Dartar Öztan, İsmail Tuncer Değim, Ahmet Nacar, Turgut Topal, Dinç Eşsiz, Ferhan Eğilmez and Gülfem Ergün. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmaceutical Sciences and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026